CONTRIBUTORS

A. Gordon Smith, MD, FAAN Brian C. Callaghan, MD, MS, FAAN

Guest Editor Associate Professor of Neurology,
Professor and Chair of Neurology, University of Michigan,
Kenneth and Dianne Wright Ann Arbor, Michigan
Distinguished Chair in Clinical
Relationship Disclosure: Dr Callaghan
and Translational Research serves on a scientific advisory board for
(Neurology), Virginia a Patient-Centered Outcomes Research
Institute grant, on the International Diabetes
Commonwealth University, Neuropathy Consortium board for the
Richmond, Virginia Peripheral Nerve Society, on the editorial
board of Neurology, and as a consultant
Relationship Disclosure: Dr Smith serves as for DynaMed. Dr Callaghan has received
a consultant for Alexion Pharmaceuticals, research/grant support from the American
Inc; Argenx; Disarm Therapeutics; Eidos Academy of Neurology, JDRF, the National
Therapeutics; and Regenesis Biomedical, Institutes of Health (R01 DK115687), and the
Inc. Dr Smith receives research/grant US Department of Veterans Affairs (Clinical
support from the National Institutes of Science Research and Development Merit
Health (U01NS095388, R01DK064814). I01CX001504) and provided consulting
services for medicolegal cases and the US
Unlabeled Use of Products/Investigational Vaccine Injury Compensation Program.
Use Disclosure: Dr Smith reports
no disclosure. Unlabeled Use of Products/Investigational
Use Disclosure: Dr Callaghan reports
no disclosure.

Ted M. Burns, MD
Harrison Distinguished
Jason L. Crowell, MD
Professor of Neurology,
Neurologist, Beth Israel
University of Virginia,
Deaconess Medical Center,
Charlottesville, Virginia
Boston, Massachusetts;
Relationship Disclosure: Dr Burns reports Jerome H. Grossman MD
no disclosure.
Graduate Fellow, Harvard
Unlabeled Use of Products/Investigational Kennedy School, Cambridge,
Use Disclosure: Dr Burns reports Massachusetts
no disclosure.
Relationship Disclosure: Dr Crowell has
received fellowship support from Medtronic.

Unlabeled Use of Products/Investigational

Use Disclosure: Dr Crowell reports no disclosure.

1122 O C TO B ER 2 0 2 0

Copyright © American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

 Lauren Elman, MD
Associate Professor of Neurology,
Perelman School of Medicine at
the University of Pennsylvania,
Philadelphia, Pennsylvania
Relationship Disclosure: Dr Elman serves on
advisory boards for Biogen and Genentech,
Inc, and receives publishing royalties from
UpToDate, Inc.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Elman discusses
the unlabeled/investigational use of
anticholinergics, clonazepam, levetiracetam,
mexiletine, mirtazapine, phenytoin, selective
serotonin reuptake inhibitors, steroids, and
tricyclic antidepressants for the treatment
of amyotrophic lateral sclerosis and other
motor neuron diseases.
Christopher H. Gibbons, MD,
MMSc, FAAN
Associate Professor of Neurology,
Harvard Medical School,
Boston, Massachusetts
Relationship Disclosure: Dr Gibbons has
received personal compensation for
serving as a scientific advisor for
Lundbeck and Theravance Biopharma
and as an associate editor for Autonomic
Neuroscience: Basic and Clinical,
research/grant support from Grifols,
and publishing royalties from UpToDate, Inc.
Dr Gibbons has held stock/stock options in
Cutaneous Neurodiagnostics, LLC, and has
given expert medical testimony.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Gibbons reports
no disclosure.
C O N T I N U U M J O U R N A L .C O M
Copyright © American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Kelly Gwathmey, MD
Assistant Professor of
Neurology; Chief, Division of
Neuromuscular Medicine,
Virginia Commonwealth
University, Richmond, Virginia
Relationship Disclosure: Dr Gwathmey
has served as a consultant for and
received personal compensation for
speaking engagements from Alexion
Pharmaceuticals, Inc.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Gwathmey discusses
the unlabeled/investigational use of
azathioprine, bortezomib, corticosteroids
(methylprednisolone, prednisone),
cyclophosphamide, cyclosporine,
methotrexate, mycophenolate mofetil,
and rituximab for the treatment of
chronic inflammatory demyelinating
polyradiculoneuropathy and its variants.
Chafic Karam, MD
Associate Professor, Department
of Neurology, Hospital of the
University of Pennsylvania,
Philadelphia, Pennsylvania
Relationship Disclosure: Dr Karam has served
as a deputy editor for Neurology and as a
consultant for Acceleron Pharma, Inc; Akcea
Therapeutics; Alnylam Pharmaceuticals, Inc;
Argenx; Biogen; CSL Behring; and Sanofi
Genzyme. Dr Karam has received personal
compensation for speaking engagements
from Akcea Therapeutics; Alnylam
Pharmaceuticals, Inc; CSL Behring;
and Sanofi Genzyme and research/grant
support from Akcea Therapeutics and
Sanofi Genzyme.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Karam discusses
the unlabeled/investigational use of
cyclophosphamide, immunoglobulin,
rituximab, and steroids in the treatment of
vasculitis and immune-mediated neuropathy
in rheumatologic disorders.
1123
CONTRIBUTORS (CONTINUED)

Christopher J. Klein, MD, FAAN Michelle L. Mauermann,

Professor of Neurology, Mayo MD, FAAN
Clinic, Rochester, Minnesota Professor of Neurology,
Neuromuscular Division of
Relationship Disclosure: Dr Klein serves on
the clinical expert and therapy boards of the Neurology, Mayo Clinic College
Charcot-Marie-Tooth Association. Dr Klein of Medicine and Science,
has received personal compensation for
speaking engagements at the Neuropathic
Rochester, Minnesota
Pain Symposium and research/grant
Relationship Disclosure: Dr Mauermann
support from the Mayo Clinic Center for
serves on the editorial board of Mayo Clinic
Individualized Medicine.
Proceedings; receives research/grant
support from Alnylam Pharmaceuticals,
Unlabeled Use of Products/Investigational
Inc, and Ionis Pharmaceuticals, Inc; and
Use Disclosure: Dr Klein reports
receives publishing royalties from Oxford
no disclosure.
University Press.

Unlabeled Use of Products/Investigational

Use Disclosure: Dr Mauermann discusses
Zachary N. London, MD, FAAN the unlabeled/investigational use of IV
James W. Albers Collegiate immunoglobulin and rituximab for the
Professor of Neurology and treatment of IgM neuropathy.

Clinical Professor of Neurology,

University of Michigan Medical
School, Ann Arbor, Michigan Elie Naddaf, MD
Assistant Professor of
Relationship Disclosure: Dr London Neurology, Mayo Clinic College
has received personal compensation
for speaking engagements from the of Medicine and Science,
American Academy of Neurology, the Rochester, Minnesota
American Association of Neuromuscular &
Electrodiagnostic Medicine, the American Relationship Disclosure: Dr Naddaf reports
Clinical Neurophysiology Society, the no disclosure.
University of Pennsylvania, and the
University of Rochester. Unlabeled Use of Products/Investigational
Use Disclosure: Dr Naddaf discusses
Unlabeled Use of Products/Investigational the unlabeled/investigational use of IV
Use Disclosure: Dr London reports immunoglobulin and rituximab for the
no disclosure. treatment of IgM neuropathy.

Jessica Rose Nance, MD

Assistant Professor of Neurology,
Johns Hopkins School of Medicine,
Baltimore, Maryland
Relationship Disclosure: Dr Nance receives
research/grant support from AveXis, Inc;
Biogen; Catabasis Pharmaceuticals, Inc;
Catalyst Pharmaceuticals, Inc; Cytokinetics,
Inc; Santhera Pharmaceuticals; and
Scholar Rock.

Unlabeled Use of Products/Investigational

Use Disclosure: Dr Nance reports no
disclosure.

1124 O C TO B ER 2 0 2 0

Copyright © American Academy of Neurology. Unauthorized reproduction of this article is prohibited.

 Amanda C. Peltier, MD, MS
Associate Professor of
Neurology; Associate Professor
of Medicine, Director of
Cardiology, Heart and Vascular
Institute, Vanderbilt University
Medical Center, Nashville,
Tennessee
Relationship Disclosure: Dr Peltier serves
as secretary of the International Diabetes
Neuropathy Consortium, on the board
of directors of the American Autonomic
Society, and on advisory boards for Akcea
Therapeutics; Alnylam Pharmaceuticals,
Inc; and CSL Behring. Dr Peltier has received
personal compensation for speaking
engagements from Akcea Therapeutics and
CSL Behring and research/grant support
from Akcea Therapeutics, CSL Behring,
and the National Institute of Neurological
Disorders and Stroke NeuroNEXT.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Peltier discusses
the unlabeled/investigational use of
a-lipoic acid, amitriptyline, cannabidiol
oil, carbamazepine, nortriptyline,
oxcarbazepine, spinal cord stimulators,
valproic acid, and venlafaxine for the
treatment of neuropathic pain in
polyneuropathy.
C O N T I N U U M J O U R N A L .C O M
Copyright © American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
Colin Quinn, MD
Assistant Professor of Clinical
Neurology, University of
Pennsylvania, Philadelphia,
Pennsylvania
Relationship Disclosure: Dr Quinn serves on
advisory boards for Acceleron Pharma, Inc,
and Amylyx Pharmaceuticals and as a
consultant for Amicus Therapeutics,
Inc. Dr Quinn receives research/grant
support from Acceleron Pharma, Inc;
Amicus Therapeutics, Inc; and Amylyx
Pharmaceuticals.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Quinn discusses
the unlabeled/investigational use
of anticholinergics, clonazepam,
levetiracetam, mexiletine, mirtazapine,
phenytoin, selective serotonin reuptake
inhibitors, steroids, and tricyclic
antidepressants for the treatment of
amyotrophic lateral sclerosis and other
motor neuron diseases.
Kazim A. Sheikh, MBBS
Professor of Neurology,
McGovern Medical School,
University of Texas; Director,
Neuromuscular Program,
Houston Health Science
Center, Houston, Texas
Relationship Disclosure: Dr Sheikh serves
on the medical advisory board of the
GBS/CIDP Foundation International and on
the editorial board of Scientific Reports.
Dr Sheikh has received personal
compensation for speaking engagements
from CSL Behring and research/grant
support from the Department of Defense
(W81XWH-18-1-0422) and the National
Institute of Neurological Disorders and
Stroke (R21NS107961).
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Sheikh reports
no disclosure.
1125
 Nathan P. Staff, MD,
PhD, FAAN
Associate Professor and
Consultant of Neurology, Mayo
Clinic, Rochester, Minnesota
Relationship Disclosure: Dr Staff serves as
an associate editor of Stem Cell Research
& Therapy and receives research/grant
support from BrainStorm Cell Limited;
Disarm Therapeutics; the National Institutes
of Health (R01 CA211887); Orion Therapeutics,
LLC; and Regenerative Medicine Minnesota
(RMM 11215 CT002).
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Staff reports
no disclosure.
Derek Wood, MD
Neurologist, UW Medicine–Valley
Medical Center, Renton,
Washington
Relationship Disclosure: Dr Wood reports
no disclosure.
Unlabeled Use of Products/Investigational
Use Disclosure: Dr Wood discusses the
unlabeled/investigational use of a-lipoic acid,
amitriptyline, cannabidiol oil, carbamazepine,
nortriptyline, oxcarbazepine, spinal cord
stimulators, valproic acid, and venlafaxine
for the treatment of neuropathic pain in
polyneuropathy.

Self-Assessment and CME Test Writers

Douglas J. Gelb, MD, PhD, FAAN D. Joanne Lynn, MD, FAAN

Professor of Neurology, Associate Dean for Student
University of Michigan, Life, Clinical Professor of
Ann Arbor, Michigan Neurology, The Ohio State
University College of Medicine,
Relationship Disclosure: Dr Gelb receives
royalties from MedLink, Oxford University Columbus, Ohio
Press, and UpToDate, Inc.
Relationship Disclosure: Dr Lynn receives
Unlabeled Use of Products/Investigational book royalties from Lippincott Williams
Use Disclosure: Dr Gelb reports & Wilkins and holds stock in Abbott
no disclosure. Laboratories; AbbVie Inc; Amgen Inc;
Bristol-Myers Squibb Company; CVS Health
Corporation; Express Scripts Holding
Company; General Electric; Merck & Co, Inc;
and Zimmer Biomet.

Unlabeled Use of Products/Investigational

Use Disclosure: Dr Lynn reports no disclosure.

1126 O C TO B ER 2 0 2 0

Copyright © American Academy of Neurology. Unauthorized reproduction of this article is prohibited.